BortiRel (Bortezomib) Injection

BortiRel, is an prescription medication. Its used to treat adult patients with multiple myeloma and mantle cell lymphoma who have received at least one prior therapy. Multiple myeloma, also known as myeloma, is a type of bone marrow cancer it affects several areas of the body, such as the spine, skull, pelvis, and ribs. Mantle cell lymphoma (MCL) is a rare type of non-Hodgkin lymphoma (NHL). It develops when B-cells (also called B-lymphocytes) become abnormal. B-cells are white blood cells that fight infection.

Facts of  (Bortezomib)
Trade Name: BortiRel
Generic Name: Bortezomib
Date of Approval: 2023
Dosage Forms & Strength: For injection: Single-dose vial contains 3.5 mg of bortezomib as lyophilized powder for reconstitution and withdrawal of the appropriate individual patient dose.
Manufacturer: Reliance Life Sciences

Bortezomib, marketed under the brand name BortiRel , is an prescription medication that has been approved by the FDA for use in the treatment of Colon Cancer. On request Bortezomib is available in several countries including the UAE, Saudi Arabia, Argentina, Brazil, UK, Hungary, Ireland, Latvia, Slovakia, Czech Republic, Belgium, Lithania, Greece, Spain, Zimbabwe, Australia, and New Zealand. To obtain Bortezomib medication, you can reach out to Verve Biosciences, a authorized pharmaceutical exporter, supplier, and distributor of anti-cancer drugs. You can contact them at urgent@cancermedicinesnetwork.com or call a customer support or WhatsApp your query

Get In Touch

Get in touch with us at Verve Biscience, and one of our team will be on hand to help with any queries you may have.

The Verve Biscience is open
Monday to Saturday.
Business hours: 10.00 A.M to 06.00 P.M.

Contact Number:
M:+91-9910645395

Email ID:
info@cancermedicinesnetwork.com
rakeshkhanna.rk@gmail.com

Description

Bortezomib, marketed under the brand name BortiRel, It is an prescription medication that has been approved bortezomib (brand name Velcade) on May 13, 2003. Bortezomib is an injectable drug used to treat multiple myeloma and mantle cell lymphoma.

What is BortiRel (Bortezomib) ?

Bortezomib, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. This includes multiple myeloma in those who have and have not previously received treatment. It is generally used together with other medications. It is given by injection.

Common side effects include nausea, diarrhea, tiredness, low platelets, fever, numbness, low white blood cells, shortness of breath, rash and abdominal pain. Other severe side effects include low blood pressure, tumour lysis syndrome, heart failure, and reversible posterior leukoencephalopathy syndrome. It is in the class of medications known as proteasome inhibitor. It works by inhibiting proteasomes, cellular complexes that break down proteins.

Bortezomib was approved for medical use in the United States in 2003 and in the European Union in 2004. It is on the World Health Organization’s List of Essential Medicines.

Source Contents Click Here

How to order approved ” BortiRel (Bortezomib) for Injection” Medicine?

BortiRel (Bortezomib) Injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing BortiRel and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.

About Healthcare Consultant

Rakesh brings an experience of 37 years in the pharmaceutical industry at various roles and responsibilities in Indian and US pharma MNCs. His areas of operations have been India and Southeast Asia, and he has been running a successful pharma business since 2010.

Testimonials

Frequently Asked Questions (FAQs)

No. At present. This medicine is not approved by the Drug Controller General Of India (DCGI).

It is a prescription medicine. You should have a VALID and RECENT Prescription.

No, we do not sell rather we just FACILITATE the Procurement of this Medicine in India

Yes, We do. Since we facilitate the Procurement of Medicines directly from the International companies and that too with all Legal Documents like International Comp. Invoice, Air Way Bill (AWB) and Bill Of Entry (BOE), we Guarantee for it.

It would take you 12-17 Working Days as it requires Govt Approvals/Certificates and coordination with an International company.

A detailed answer to provide information about your business, build trust with potential customers, or help the visitor with a problem they may be encountering

A detailed answer to provide information about your business, build trust with potential customers, or help the visitor with a problem they may be encountering

We are 24 Hours * 7 Days Available through our Website and Mobile Numbers?

Related Products

WhatsApp Us